文献速递神经介入CTMRDSA

评估散发性颅内海绵状血管畸形相关发育性静脉异常:C臂对比增强锥形束CT在常规对比增强MRI之外的附加诊断价值

Evaluation of sporadic intracranial cavernous malformations for detecting associated developmental venous anomalies: added diagnostic value of C-arm contrast-enhanced cone-beam CT to routine contrast-enhanced MRI.
PubMed 文献 · Eur Radiol · 2018-07-31

研究纳入56例散发性颅内海绵状血管畸形患者,回顾性独立评估常规1.5T对比增强MRI与C臂对比增强锥形束CT检测相关发育性静脉异常的表现,以对比增强MRI为参考标准。对比增强锥形束CT在常规对比增强MRI阴性的19例中使10例(52.6%)获得新诊断,其敏感度100%、特异度47.3%、AUC 0.737。作者认为对比增强锥形束CT在常规对比增强MRI阴性患者中检测相关发育性静脉异常有用。

要点

  • 对比增强锥形束CT在常规对比增强MRI阴性患者中可新检出相关发育性静脉异常。
  • 对比增强锥形束CT检测相关发育性静脉异常的敏感度为100%、特异度为47.3%。
  • 对比增强锥形束CT观察者内与观察者间一致性均为优秀。

核心结论

  • 对比增强锥形束CT在检测海绵状血管畸形相关发育性静脉异常方面是有用的成像技术,尤其适用于常规对比增强MRI阴性的患者。
  • 在近半数常规对比增强MRI阴性的这类患者中,对比增强锥形束CT将相关发育性静脉异常作为新诊断揭示出来。

研究设计与样本

  • 回顾性研究,纳入56例散发性颅内海绵状血管畸形患者,其中53例为单发、3例为双发。
  • 所有患者均行1.5特斯拉常规对比增强MRI扫描,并获取对比增强锥形束CT图像。
  • 图像由两名观察者独立回顾性判读,意见不一致时由第三名观察者共识裁定;以对比增强MRI为参考标准。

关键影像表现/征象

  • 对比增强MRI上37例(56例中的66%)发现相关发育性静脉异常,对比增强锥形束CT上47例(56例中的84%)发现相关发育性静脉异常。
  • 在对比增强MRI阴性的19例中,对比增强锥形束CT使10例(52.6%)获得新诊断。
  • 9例(56例中的16%)在两种成像技术上均未见发育性静脉异常。

诊断标准与关键数值

  • 对比增强锥形束CT检测相关发育性静脉异常的敏感度为100%(95%CI:90.5-100%)。
  • 对比增强锥形束CT检测相关发育性静脉异常的特异度为47.3%(95%CI:24.4-71.1%)。
  • 对比增强锥形束CT检测相关发育性静脉异常的阳性似然比为1.9(95%CI:1.240-2.911),曲线下面积为0.737(95%CI:0.602-0.845)。
  • 对比增强MRI观察者内一致性优秀,κ=0.960;对比增强锥形束CT观察者内一致性优秀,κ=0.931。
  • 对比增强MRI观察者间一致性为中等至高度(原文为substantial),κ=0.803;对比增强锥形束CT观察者间一致性优秀,κ=0.810。

临床应用与阅片要点

  • 对于常规对比增强MRI未显示相关发育性静脉异常的海绵状血管畸形患者,对比增强锥形束CT可在近半数中揭示相关发育性静脉异常这一新诊断。
  • 对比增强锥形束CT检测相关发育性静脉异常具有高敏感度,但特异度有限(47.3%),阅片时需结合对比增强MRI综合判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Our purpose was to investigate the added diagnostic value of C-arm contrast-enhanced cone-beam CT (CE-CBCT) to routine contrast-enhanced MRI (CE-MRI) in detecting associated developmental venous anomalies (DVAs) in patients with sporadic intracranial cavernous malformations (ICMs).

METHODS: Fifty-six patients (53 with single and three with double ICMs) met the inclusion criteria. All patients had routine CE-MRI scans performed at 1.5 Tesla. The imaging studies (CE-MRI and CE-CBCT) were retrospectively and independently reviewed by two observers, with consensus by a third. Group difference, intra- and interobserver agreement, and diagnostic performance of the modalities in detecting associated DVAs were calculated. Reference standard was CE-MRI.

RESULTS: On CE-MRI and CE-CBCT, 37 (66%; of 56) and 47 patients (84%; of 56) had associated DVAs, respectively. In 10 patients (52.6%; of CE-MRI negatives [n=19]), CE-CBCT improved the diagnosis. Nine patients (16%; of 56) had no DVA on both imaging techniques. Difference in proportions of associated DVAs on CE-MRI and CE-CBCT was statistically significant, p < 0.05. Sensitivity, specificity, positive likelihood ratio, and area under the curve of CE-CBCT were 100% (95% confidence interval [CI]: 90.5-100%), 47.3% (95% CI: 24.4-71.1%), 1.9 (95%CI: 1.240-2.911), 0.737 (95%CI: 0.602-0.845), respectively. Intraobserver agreement was excellent for CE-MRI, kappa (κ) coefficient = 0.960, and CE-CBCT, κ=0.931. Interobserver agreement was substantial for CE-MRI, κ=0.803, and excellent for CE-CBCT, κ=0.810.

CONCLUSIONS: CE-CBCT is a useful imaging technique especially in patients with negative routine CE-MRI in terms of detecting associated DVAs. In nearly half of these particular patients, it reveals an associated DVA as a new diagnosis.

KEY POINTS: • Although it is known to be the gold standard, some of the DVAs associated with ICMs are underdiagnosed with CE-MRI. • In nearly half of the patients with negative routine CE-MRI, CE-CBCT reveals an associated DVA as a new diagnosis. • Intra- and interobserver agreement on CE-CBCT is excellent in terms of detecting associated DVAs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kocak B, Kizilkilic O, Zeynalova A, et al. Evaluation of sporadic intracranial cavernous malformations for detecting associated developmental venous anomalies: added diagnostic value of C-arm contrast-enhanced cone-beam CT to routine contrast-enhanced MRI. Eur Radiol. 2018. PMID: 30066249. doi:10.1007/s00330-018-5652-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。